Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;30(8):1050-1061.
doi: 10.1016/j.joca.2022.03.012. Epub 2022 Apr 20.

Advances in organ-on-a-chip systems for modelling joint tissue and osteoarthritic diseases

Affiliations
Free article
Review

Advances in organ-on-a-chip systems for modelling joint tissue and osteoarthritic diseases

L Banh et al. Osteoarthritis Cartilage. 2022 Aug.
Free article

Erratum in

Abstract

Joint-on-a-chip (JOC) models are powerful tools that aid in osteoarthritis (OA) research. These microfluidic devices apply emerging organ-on-a-chip technology to recapitulate a multifaceted joint tissue microenvironment. JOCs address the need for advanced, dynamic in vitro models that can mimic the in vivo tissue environment through joint-relevant biomechanical or fluidic integration, an aspect that existing in vitro OA models lack. There are existing review articles on OA models that focus on animal, tissue explant, and two-dimensional and three-dimensional (3D) culture systems, including microbioreactors and 3D printing technology, but there has been limited discussion of JOC models. The aim of this article is to review recent developments in human JOC technology and identify gaps for future advancements. Specifically, mechanical stimulation systems that mimic articular movement, multi-joint tissue cultures that enable crosstalk, and systems that aim to capture aspects of OA inflammation by incorporating immune cells are covered. The development of an advanced JOC model that captures the dynamic joint microenvironment will improve testing and translation of potential OA therapeutics.

Keywords: In vitro models; Microfluidics; Organ-on-a-chip; Osteoarthritis; Tissue engineering.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest LB, KKC, and MWYC declare no conflict of interest exists. EY is currently Chief Technology Officer of Lynx Biosciences, Inc., which has no conflict with this manuscript. SV is CEO/President of a Regulatory Company which has no conflict with this manuscript.

Publication types

LinkOut - more resources